Home > Insider Trading > Filing (0001209191-21-067893)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087294	Cumberland Pharmaceuticals Inc	CPIX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1490829	James Jones	2525 West End Avenue Suite 950 Nashville TN 37203		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-11-01	42	$2.67	18,102	No	4	P	Direct
Common Stock	Acquisiton	2021-11-02	42	$2.63	18,144	No	4	P	Direct
Common Stock	Acquisiton	2021-11-03	42	$2.71	18,186	No	4	P	Direct
Common Stock	Acquisiton	2021-11-04	42	$2.73	18,228	No	4	P	Direct
Common Stock	Acquisiton	2021-11-05	42	$2.71	18,270	No	4	P	Direct
Common Stock	Acquisiton	2021-11-08	42	$2.95	18,312	No	4	P	Direct
Common Stock	Acquisiton	2021-11-09	42	$3.21	18,354	No	4	P	Direct
Common Stock	Acquisiton	2021-11-10	42	$2.94	18,396	No	4	P	Direct
Common Stock	Acquisiton	2021-11-11	42	$2.83	18,438	No	4	P	Direct
Common Stock	Acquisiton	2021-11-12	42	$2.67	18,480	No	4	P	Direct
Common Stock	Acquisiton	2021-11-15	42	$2.71	18,522	No	4	P	Direct
Common Stock	Acquisiton	2021-11-16	42	$2.66	18,564	No	4	P	Direct
Common Stock	Acquisiton	2021-11-17	42	$2.58	18,606	No	4	P	Direct
Common Stock	Acquisiton	2021-11-18	42	$2.58	18,648	No	4	P	Direct
Common Stock	Acquisiton	2021-11-19	42	$2.55	18,690	No	4	P	Direct
Common Stock	Acquisiton	2021-11-22	42	$2.35	18,732	No	4	P	Direct
Common Stock	Acquisiton	2021-11-23	42	$2.29	18,774	No	4	P	Direct
Common Stock	Acquisiton	2021-11-24	42	$2.31	18,816	No	4	P	Direct
Common Stock	Acquisiton	2021-11-26	42	$2.26	18,858	No	4	P	Direct
Common Stock	Acquisiton	2021-11-29	42	$2.23	18,900	No	4	P	Direct
Common Stock	Acquisiton	2021-11-30	42	$4.61	18,942	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.